Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors

Histone deacetylases (HDACs) induce deacetylation of both histone and non-histone proteins and play a critical role in the modulation of physiological and pathological gene expression. Pharmacological inhibition of HDAC has been reported to attenuate progression of renal fibrogenesis in obstructed k...

Full description

Bibliographic Details
Main Authors: Shougang eZhuang, Na eLiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00121/full
_version_ 1818930043270725632
author Shougang eZhuang
Na eLiu
author_facet Shougang eZhuang
Na eLiu
author_sort Shougang eZhuang
collection DOAJ
description Histone deacetylases (HDACs) induce deacetylation of both histone and non-histone proteins and play a critical role in the modulation of physiological and pathological gene expression. Pharmacological inhibition of HDAC has been reported to attenuate progression of renal fibrogenesis in obstructed kidney and reduce cyst formation in polycystic kidney disease. HDAC inhibitors (HDACis) are also able to ameliorate renal lesions in diabetes nephropathy, lupus nephritis, aristolochic acid nephropathy and transplant nephropathy. The beneficial effects of HDACis are associated with their anti-fibrosis, anti-inflammation, and immmunosuppressant effects. In this review, we summarize recent advances on the treatment of various chronic kidney diseases with HDACis in preclinical models.
first_indexed 2024-12-20T03:54:25Z
format Article
id doaj.art-62b6407ad69841c1aabf68422f5a28ab
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-20T03:54:25Z
publishDate 2015-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-62b6407ad69841c1aabf68422f5a28ab2022-12-21T19:54:22ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2015-04-01610.3389/fphys.2015.00121131997Treatment of Chronic Kidney Diseases with Histone Deacetylase InhibitorsShougang eZhuang0Na eLiu1Rhode Island Hospital and Aplert Medical School, Brown UniversityShanghai East Hospital, Tongji University School of MedicineHistone deacetylases (HDACs) induce deacetylation of both histone and non-histone proteins and play a critical role in the modulation of physiological and pathological gene expression. Pharmacological inhibition of HDAC has been reported to attenuate progression of renal fibrogenesis in obstructed kidney and reduce cyst formation in polycystic kidney disease. HDAC inhibitors (HDACis) are also able to ameliorate renal lesions in diabetes nephropathy, lupus nephritis, aristolochic acid nephropathy and transplant nephropathy. The beneficial effects of HDACis are associated with their anti-fibrosis, anti-inflammation, and immmunosuppressant effects. In this review, we summarize recent advances on the treatment of various chronic kidney diseases with HDACis in preclinical models.http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00121/fullHistone DeacetylasesLupus Nephritischronic kidney diseasesrenal fibrosisDiabetes nephropathyrenal fibroblasts
spellingShingle Shougang eZhuang
Na eLiu
Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
Frontiers in Physiology
Histone Deacetylases
Lupus Nephritis
chronic kidney diseases
renal fibrosis
Diabetes nephropathy
renal fibroblasts
title Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
title_full Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
title_fullStr Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
title_full_unstemmed Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
title_short Treatment of Chronic Kidney Diseases with Histone Deacetylase Inhibitors
title_sort treatment of chronic kidney diseases with histone deacetylase inhibitors
topic Histone Deacetylases
Lupus Nephritis
chronic kidney diseases
renal fibrosis
Diabetes nephropathy
renal fibroblasts
url http://journal.frontiersin.org/Journal/10.3389/fphys.2015.00121/full
work_keys_str_mv AT shougangezhuang treatmentofchronickidneydiseaseswithhistonedeacetylaseinhibitors
AT naeliu treatmentofchronickidneydiseaseswithhistonedeacetylaseinhibitors